Biocept Prices $5M Public Offering
The San Diego-based company plans to use the proceeds to advance its cerebral spinal fluid liquid biopsy assay, as well as to boost its working capital.
In Brief This Week: Biocept, Quest, Agilent, MDxHealth, OpGen, More
News items for the week of May 15, 2023.
In Brief This Week: Thermo Fisher Scientific, Danaher, Accelerate Diagnostics, Oncocyte, More
News items for the week of May 8, 2023.
In Brief This Week: Quest Diagnostics, Abbott, Biocept, Biocartis, Angle, Virax Biolabs
News items for the week of April 17, 2023.
Biocept to Lay Off 35 Percent of Staff, Explore Strategic Alternatives
The company is hoping to preserve its cash runway and find a way to derive some value for its shareholders from its cerebrospinal fluid assay CNSide.
Aug 16, 2021
Biocept Q2 Revenues Continue COVID-19-Driven Spike
Mar 31, 2021